Literature DB >> 6292959

Anorexia and hyperphagia produced by five pharmacologic classes of hallucinogens.

D B Vaupel, E C Morton.   

Abstract

The acute actions of five prototype hallucinogens administered SC on food consumption in 23 hr food deprived dogs were compared with the anorexic effect of d-amphetamine and the hyperphagic effect of sodium pentobarbital. Comparisons were made on the basis of dose-response relationships. Among the hallucinogens decreasing food intake, both LSD and atropine produced substantial anorexia, but the slopes of their dose-response curves were clearly different from d-amphetamine. Phencyclidine and the opioid SKF 10,047 suppressed food intake also; their individual dose-effect curves were parallel to the amphetamine curve, although both were less potent. Of the hallucinogens tested, only delta-9-tetrahydrocannabinol (delta 9-THC) stimulated food consumption, and though it was less potent, it resembled pentobarbital both qualitatively and by having a parallel dose-response curve. The appetitive responses are discussed in relation to other pharmacologic actions of these hallucinogens in the dog, and consideration is given to the possible modes of action for phencyclidine- and SKF 10,047-induced anorexia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292959     DOI: 10.1016/0091-3057(82)90316-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

Review 1.  The endocannabinoid system: role in energy regulation.

Authors:  Thomas F Gamage; Aron H Lichtman
Journal:  Pediatr Blood Cancer       Date:  2012-01       Impact factor: 3.167

2.  Evidence for multiple opiate receptor involvement in different phencyclidine-induced unconditioned behaviors in rats.

Authors:  B D Greenberg; D S Segal
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome.

Authors:  Shira Hirsch; Joseph Tam
Journal:  Toxins (Basel)       Date:  2019-05-15       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.